1. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate
- Author
-
Mariko Riley, Katie Stamp, Xinde Zheng, Yan Ren, Kate Blease, Chin-Chun Lu, Julia Hui, Lawrence G Hamann, Philip P Chamberlain, Gang Lu, Polat Abdubek, Mary E Matyskiela, Gondi Kumar, Maria Wang, Wei Fang, Aaron Carpenter, Thomas Clayton, Clifton Drew, Suzana Couto, Chung-Wein Lee, Mark Rolfe, Rupert Vessey, and James Hartke
- Subjects
Male ,0301 basic medicine ,Ubiquitin-Protein Ligases ,Transgene ,Induced Pluripotent Stem Cells ,Mice, Transgenic ,Nerve Tissue Proteins ,Phocomelia ,Protein degradation ,Ligands ,medicine.disease_cause ,01 natural sciences ,Mice ,03 medical and health sciences ,SALL4 ,Testis ,Animals ,Humans ,Medicine ,Molecular Biology ,Adaptor Proteins, Signal Transducing ,Zinc finger ,Mutation ,010405 organic chemistry ,business.industry ,Cereblon ,Homozygote ,Zinc Fingers ,Cell Biology ,medicine.disease ,Immunohistochemistry ,eye diseases ,Thalidomide ,0104 chemical sciences ,DNA-Binding Proteins ,Teratogens ,030104 developmental biology ,Gene Expression Regulation ,Proteolysis ,Cancer research ,Rabbits ,business ,Peptide Hydrolases ,Transcription Factors ,medicine.drug - Abstract
Targeted protein degradation via small-molecule modulation of cereblon offers vast potential for the development of new therapeutics. Cereblon-binding therapeutics carry the safety risks of thalidomide, which caused an epidemic of severe birth defects characterized by forelimb shortening or phocomelia. Here we show that thalidomide is not teratogenic in transgenic mice expressing human cereblon, indicating that binding to cereblon is not sufficient to cause birth defects. Instead, we identify SALL4 as a thalidomide-dependent cereblon neosubstrate. Human mutations in SALL4 cause Duane-radial ray, IVIC, and acro-renal-ocular syndromes with overlapping clinical presentations to thalidomide embryopathy, including phocomelia. SALL4 is degraded in rabbits but not in resistant organisms such as mice because of SALL4 sequence variations. This work expands the scope of cereblon neosubstrate activity within the formerly 'undruggable' C2H2 zinc finger family and offers a path toward safer therapeutics through an improved understanding of the molecular basis of thalidomide-induced teratogenicity.
- Published
- 2018
- Full Text
- View/download PDF